Lemmy Today

1,474 readers
88 users here now

Welcome to lemmy.today!

About us

🤗 Thanks for joining our little instance here, located in Oregon. The idea is to have a fast, stable instance and allow users to subscribe to whatever content they want from here.

😎 We dont block any other instances. We will keep it that way unless it becomes a moderation problem.

🤠 We will be around for a very long time, so you dont have to worry about us shutting down the instance anytime soon. We like performance and stability in our servers, and will upgrade the instance when its needed.

🥹 Make sure to join a lot of remote communities to get a good feed going. How to do that is explained here.

Lemmy mobile apps

You should start using one of these ASAP since the web browser user interface is quite ugly, even with themes.

Sync for Lemmy (Android)
Boost for Lemmy (Android)
Eternity (Android)
Liftoff (Android and IOS)
Voyager (IOS)
Voyager WebApp
Jerboa (Android)
Connect (Android)
Thunder (Android and IOS)
Mlem (IOS)
Memmy (IOS)

Optional Lemmy web browser user interfaces

Rules

Be respectful. Everyone should feel welcome here.
No bigotry - including racism, sexism, ableism, homophobia, transphobia, or xenophobia.
No Ads / Spamming, or creating communities to promote blogs or services.
No local pornography communities (but you are free to subscribe to them on other instances if you wish).
No local communities about software related to porn.
No local religious communities (use remote ones)

Contact the admin

@mrmanager

founded 1 year ago

ADMINS

mrmanager

Buelldozer

448

FDA approves cure for sickle cell disease, the first treatment to use CRISPR (www.nbcnews.com)

submitted 8 months ago by misk@sopuli.xyz to c/technology@lemmy.world

31 comments fedilink

FDA approves cure for sickle cell disease, the first treatment to use CRISPR (www.nbcnews.com)

submitted 8 months ago by MicroWave@lemmy.world to c/health@lemmy.world

5 comments fedilink

The groundbreaking approval has been eagerly anticipated by patients and doctors alike. The treatment is expected to be extremely expensive.

The Food and Drug Administration on Friday approved a powerful treatment for sickle cell disease, a devastating illness that affects more than 100,000 Americans, the majority of whom are Black.

The therapy, called Casgevy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is the first medicine to be approved in the United States that uses the gene-editing tool CRISPR, which won its inventors the Nobel Prize in chemistry in 2020.

“I think this is a pivotal moment in the field,” said Dr. Alexis Thompson, chief of the division of hematology at Children’s Hospital of Philadelphia, who has previously consulted for Vertex. “It’s been really remarkable how quickly we went from the actual discovery of CRISPR, the awarding of a Nobel Prize, and now actually seeing it being an approved product.”